A clinical study of the effects of Zoledronic Acid in the prevention of metastasis of breast cancer to bone, and impact for disease process of breast cancer patients.

Trial Profile

A clinical study of the effects of Zoledronic Acid in the prevention of metastasis of breast cancer to bone, and impact for disease process of breast cancer patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Breast cancer; Cancer metastases
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned end date changed from 1 Jan 2010 to 31 Jan 2015 as reported by Chinese Clinical Trial Register.
    • 24 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top